Ixabepilone - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for ixabepilone and what is the scope of freedom to operate?
Ixabepilone
is the generic ingredient in one branded drug marketed by R-pharm Us Llc and is included in one NDA. There is one patent protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.Ixabepilone has thirty-four patent family members in twenty-six countries.
There is one drug master file entry for ixabepilone. One supplier is listed for this compound.
Summary for ixabepilone
International Patents: | 34 |
US Patents: | 1 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 56 |
Clinical Trials: | 114 |
Patent Applications: | 7,346 |
What excipients (inactive ingredients) are in ixabepilone? | ixabepilone excipients list |
DailyMed Link: | ixabepilone at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for ixabepilone
Generic Entry Date for ixabepilone*:
Constraining patent/regulatory exclusivity:
Dosage:
INJECTABLE;INTRAVENOUS |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Recent Clinical Trials for ixabepilone
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Allarity Therapeutics | Phase 2 |
R-Pharm US, Inc. | Phase 2 |
Yale University | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for ixabepilone
Paragraph IV (Patent) Challenges for IXABEPILONE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
IXEMPRA KIT | Injection | ixabepilone | 15 mg/vial and 45 mg/vial, single- use vials | 022065 | 1 | 2012-04-16 |
US Patents and Regulatory Information for ixabepilone
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-002 | Oct 16, 2007 | RX | Yes | Yes | 7,312,237*PED | ⤷ Subscribe | Y | ⤷ Subscribe | |||
R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-001 | Oct 16, 2007 | RX | Yes | Yes | 7,312,237*PED | ⤷ Subscribe | Y | ⤷ Subscribe | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ixabepilone
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-002 | Oct 16, 2007 | 6,605,599 | ⤷ Subscribe |
R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-001 | Oct 16, 2007 | 6,605,599 | ⤷ Subscribe |
R-pharm Us Llc | IXEMPRA KIT | ixabepilone | INJECTABLE;INTRAVENOUS | 022065-002 | Oct 16, 2007 | RE41393*PED | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ixabepilone
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Brazil | 0207961 | ⤷ Subscribe | |
Estonia | 200300440 | ⤷ Subscribe | |
Croatia | P20030831 | KOMBINACIJA ANALOGA EPOTILONA I KEMOTERAPIJSKIH SREDSTAVA ZA LIJEČENJE PROLIFERATIVNIH OBOLJENJA (COMBINATION OF EPOTHILONE ANALOGS AND CHEMOTHERAPEUTIC AGENTS FOR THE TREATMENT OF PROLIFERATIVE DISEASES) | ⤷ Subscribe |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for ixabepilone
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1019389 | C01019389/01 | Switzerland | ⤷ Subscribe | PRODUCT NAME: IXABEPILONE; REGISTRATION NUMBER/DATE: SWISSMEDIC 58880 27.02.2009 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Ixabepilone Market Analysis and Financial Projection Experimental
More… ↓